Mechanism of Zushima in treating rheumatoid arthritis based on network pharmacology and molecular docking
10.3969/j.issn.1001-1978.2021.08.024
- Author:
Xu WU
1
;
Su-Rong HE
1
;
Jing WANG
1
;
Chun-Yan QI
1
;
Chong-Bo ZHAO
1
;
Jing WANG
2
;
Chong-Bo ZHAO
2
Author Information
1. Shaanxi University of Chinese Medicine
2. Engineering Technology Research Center of Shaanxi Administration of Chinese Herbal Pieces
- Publication Type:Journal Article
- Keywords:
mechanism of action;
molecular docking;
network pharmacology;
rheumatoid arthritis;
thermography;
Zushima
- From:
Chinese Pharmacological Bulletin
2021;37(8):1168-1175
- CountryChina
- Language:Chinese
-
Abstract:
Aim To investigate the potential mechanism of Zushima in the treatment of rheumatoid arthritis (RA). Methods Through PubMed literature mining, combined with tcmsp, TCMIP, Batman TCM, Pub- Chem, Swiss target prediction, GeneCards and other databases, the active ingredients, action targets and RA targets of Zushima were obtained. The active ingredient RA target pathway network was constructed by u- sing Cytoscape 3. 7. 2 software. The protein-protein interaction network was constructed by string database. David online tool was used to analyze the enrichment of GO and KEGG pathway. The molecular docking was verified in autodocking Vina and other software. Results Through screening, 22 chemical constituents were obtained, and 273 potential targets were identi fied. GO (P <0.05) enriched 1 376 GO items, mainly involving cell surface receptor connection signal transduction, plasma membrane part, nucleotide binding and so on. KEGG ( P < 0. 05) pathway analysis showed that 58 signaling pathways were involved in the focal adhesion pathway, chemokine signaling pathway, MAPK signaling pathway and so on. Conclusions The multi-component and multi-target mechanism of Zushima in treating rheumatoid arthritis can be studied by network pharmacology method, which provides scientific basis for experimental research and clinical application of Zushima.
